Literature DB >> 30730484

Computer-Assisted Navigation Is Associated with Reductions in the Rates of Dislocation and Acetabular Component Revision Following Primary Total Hip Arthroplasty.

Daniel D Bohl1, Michael T Nolte1, Kevin Ong2, Edmund Lau3, Tyler E Calkins1, Craig J Della Valle1.   

Abstract

BACKGROUND: Prior work suggests that computer-assisted navigation improves acetabular component position during primary total hip arthroplasty (THA). However, it is not known whether this translates to improvements in clinical outcomes. The purpose of this study was to test for associations between navigation use and the risk of dislocation, aseptic revision of the acetabular component, aseptic revision of the femoral component, aseptic revision of either component, and acute periprosthetic joint infection (PJI).
METHODS: This was a retrospective cohort study, conducted using the 100% Medicare Part A claims data set. Inclusion criteria were an age of ≥65 years and primary THA for osteoarthritis. First, the association between navigation use and patient and hospital characteristics was assessed. Second, while controlling for these characteristics, multivariate regression was used to test for the association of navigation use and the outcomes listed above.
RESULTS: A total of 803,732 primary THA procedures were identified; 14,540 (1.81%) involved the use of navigation. Navigation use was associated with younger age, other/unknown race, the Western census region, higher socioeconomic status, lower Charlson Comorbidity Index, shorter length of stay, private hospitals, teaching hospitals, and larger hospitals (p < 0.05 for each). Navigation use was associated with a lower rate of dislocation (1.00% versus 1.70% for no navigation; adjusted hazard ratio [HR] = 0.69; 95% confidence interval [CI] = 0.58 to 0.82; p < 0.001) and aseptic revision of the acetabular component (1.03% versus 1.55%; adjusted HR = 0.75; 95% CI = 0.64 to 0.88; p < 0.001). Navigation was not associated with aseptic revision of the femoral component (1.54% versus 1.87%; p = 0.064), aseptic revision of either component (1.91% versus 2.31%; p = 0.077), acute PJI at 6 weeks (0.34% versus 0.45%; p = 0.121), or acute PJI at 90 days (0.50% versus 0.66%; p = 0.458).
CONCLUSIONS: The findings of this study suggest that navigation is associated with reductions in the rates of dislocation and aseptic acetabular revision following primary THA. However, these results should be interpreted carefully in the setting of potential confounding by unmeasured variables, such as surgeon volume, family support, and patient compliance. Causality cannot be inferred until further prospective trials can vet this technology. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2019        PMID: 30730484     DOI: 10.2106/JBJS.18.00108

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

1.  Computer-Assisted Orthopedic and Trauma Surgery.

Authors:  Timo Stübig; Henning Windhagen; Christian Krettek; Max Ettinger
Journal:  Dtsch Arztebl Int       Date:  2020-11-20       Impact factor: 5.594

2.  Computerized navigation for total hip arthroplasty is associated with lower complications and ninety-day readmissions: a nationwide linked analysis.

Authors:  Elizabeth B Gausden; Joseph E Popper; Peter K Sculco; Barret Rush
Journal:  Int Orthop       Date:  2020-01-09       Impact factor: 3.075

3.  Does accelerometer-based portable navigation provide more accurate and precise cup orientation without prosthetic impingement than conventional total hip arthroplasty? A randomized controlled study.

Authors:  Masato Kiyohara; Satoshi Hamai; Kyohei Shiomoto; Satoru Harada; Tetsunari Harada; Goro Motomura; Satoshi Ikemura; Masanori Fujii; Shinya Kawahara; Yasuharu Nakashima
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-03-26       Impact factor: 2.924

4.  Computer Navigation for Revision Total Hip Arthroplasty Reduces Dislocation Rates.

Authors:  Abhinav K Sharma; Zlatan Cizmic; Kaitlin M Carroll; Seth A Jerabek; Wayne G Paprosky; Peter K Sculco; Alejandro Gonzalez Della Valle; Ran Schwarzkopf; David J Mayman; Jonathan M Vigdorchik
Journal:  Indian J Orthop       Date:  2022-02-24       Impact factor: 1.033

5.  Impact of Robotic Assisted Surgery on Outcomes in Total Hip Arthroplasty.

Authors:  Ethan A Remily; Austin Nabet; Oliver C Sax; Scott J Douglas; Sahir S Pervaiz; Ronald E Delanois
Journal:  Arthroplast Today       Date:  2021-04-30

6.  CORR Insights®: Does An Augmented Reality-based Portable Navigation System Improve the Accuracy of Acetabular Component Orientation During THA? A Randomized Controlled Trial.

Authors:  Brent A Ponce
Journal:  Clin Orthop Relat Res       Date:  2020-05       Impact factor: 4.755

7.  Accuracy of a portable accelerometer-based navigation system for cup placement and intraoperative leg length measurement in total hip arthroplasty: a cross-sectional study.

Authors:  Hiromasa Tanino; Yasuhiro Nishida; Ryo Mitsutake; Hiroshi Ito
Journal:  BMC Musculoskelet Disord       Date:  2021-03-23       Impact factor: 2.362

8.  Does An Augmented Reality-based Portable Navigation System Improve the Accuracy of Acetabular Component Orientation During THA? A Randomized Controlled Trial.

Authors:  Hiroyuki Ogawa; Kenji Kurosaka; Atsuko Sato; Naoyuki Hirasawa; Masaaki Matsubara; Sachiyuki Tsukada
Journal:  Clin Orthop Relat Res       Date:  2020-05       Impact factor: 4.755

9.  Trends and patient factors associated with technology-assisted total hip arthroplasty in the United States from 2005 to 2014.

Authors:  Peter P Hsiue; Clark J Chen; Cristina Villalpando; Danielle Ponzio; Amir Khoshbin; Alexandra I Stavrakis
Journal:  Arthroplast Today       Date:  2020-03-09

10.  Retained pelvic pin site debris after navigated total hip replacement: Masquerading as an early-stage chondrosarcomatous lesion.

Authors:  A P Kurmis
Journal:  J Postgrad Med       Date:  2020 Oct-Dec       Impact factor: 1.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.